Skip to main content
. 2023 Jan 25;128:335–346. doi: 10.1016/j.ijid.2023.01.018

Figure 3.

Figure 3

Adjusted overall VE.

The study by Paixao et al.[14] (symptomatic infection) was the source of heterogeneity and was removed. (a) Overall VE at 14 to 20 days after the first dose; (b) Overall VE at 21 to 27 days after the first dose; (c) Overall VE at ≥28 days after the first dose of mRNA vaccine; (d) Overall VE at ≥14 days after two doses.

CI, confidence interval; mRNA, messenger RNA; VE, vaccine effectiveness.